Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Real-World Prospective Registry Study of Integrated Traditional Chinese and Western Medicine Interventions in Patients With Obesity

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity. The study will enroll at least 10,000 individuals with obesity from urban and rural populations. Multimodal data, including electronic medical records, laboratory test results, imaging data, and lifestyle information, will be collected. The effectiveness of integrated TCM and Western medicine interventions will be assessed across different age groups, disease stages, and obesity-related constitution types. In addition, disease progression patterns and key prevention and treatment points will be explored. Health economic analyses will be conducted to evaluate the cost-effectiveness of different obesity management strategies, providing real-world evidence to support public health policy and the optimization of integrated obesity prevention and management approaches.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Age 18 years and above, gender not restricted;

• Weight fluctuation within the last 3 months is ≤ 5% and BMI is ≥ 28.0 kg/m2;

• Good compliance, willing to follow the follow-up principles;

• Agree to sign the informed consent form.

Locations
Other Locations
China
Hubei Provincial Hospital of Traditional Chinese Medicine
RECRUITING
Wuhan
Contact Information
Primary
ChenGang Professor ChenGang, Doctor
250149875@qq.com
+86 17720376888
Backup
ZhuHui ZhuHui, Doctor
865057084@qq.com
+86 13545094802
Time Frame
Start Date: 2025-11-26
Estimated Completion Date: 2028-07-31
Participants
Target number of participants: 10000
Treatments
Obesity Patients Cohort
A prospective real-world observational cohort including adult patients with obesity (BMI ≥28 kg/m²). Participants receive routine clinical care and may be exposed to integrated traditional Chinese and Western medicine interventions, pharmacologic treatments, lifestyle interventions, or other standard-of-care approaches. No randomization or predefined intervention assignment is applied.
Related Therapeutic Areas
Sponsors
Collaborators: Heilongjiang Quanle Pharmaceutical Co., Ltd., Union Hospital of Huazhong University of Science and Technology, Huazhong University of Science and Technology
Leads: Hubei Hospital of Traditional Chinese Medicine

This content was sourced from clinicaltrials.gov